Movicol Junior Neutral (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Movicol Junior Neutral, an osmotic laxative, is indicated for the management of constipation in the pediatric population.

• Constipation: softens stool and increases water content to facilitate easier passage in children.
• Functional constipation: improves stool frequency and consistency, helping to establish regular bowel habits.
• Chronic constipation: provides long‑term relief by maintaining stool softness during extended treatment courses.

• Macrogol 3350 creates an osmotic gradient within the intestinal lumen, drawing water into the bowel. The accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) maintain electrolyte balance while the increased luminal water softens feces and expands stool volume, stimulating peristalsis and promoting regular bowel movements without being absorbed systemically. This mechanism results in a gentle, non‑stimulatory laxative effect suitable for children.

Macrogol 3350 may be associated with several adverse reactions. Most are mild and transient, but clinicians should be aware of the range of possible effects.

Common Side Effects

• Abdominal bloating: a sensation of fullness or swelling in the abdomen that may be uncomfortable but usually resolves without treatment.
• Flatulence: increased intestinal gas leading to discomfort and audible passing of gas, often temporary.
• Nausea: a feeling of unease in the stomach with an urge to vomit, typically mild.
• Diarrhoea: frequent loose or watery stools that can cause mild dehydration if not managed.

Serious or Rare Side Effects

• Severe electrolyte imbalance: significant disturbances in sodium, potassium, or chloride levels that may require medical monitoring and intervention.
• Allergic reaction: symptoms such as rash, itching, swelling, or hives indicating hypersensitivity, which may necessitate discontinuation of therapy.

When prescribing Movicol Junior Neutral, several precautions should be considered to ensure safe use in pediatric patients.

• Assess hydration status: ensure the child is not dehydrated before initiating therapy.
• Monitor electrolyte balance: regular checks of sodium and potassium levels are advisable during prolonged use.
• Use in renal impairment with caution: adjust therapy if the patient has reduced kidney function.
• Avoid in bowel obstruction: contraindicated in cases of mechanical obstruction or perforated bowel.
• Store at ambient temperature: keep the oral solution below 25 °C, in the original container, protected from moisture and direct sunlight.

Macrogol 3350 can interact with other medicines, affecting absorption or electrolyte balance.

Major Interactions (Avoid)

• Antacids containing aluminium or magnesium: may reduce laxative effectiveness.
• Loop diuretics (e.g., furosemide): increase risk of electrolyte disturbances when combined.

Moderate Interactions (Monitor Closely)

• Oral rehydration salts: concurrent use may alter electrolyte composition; monitor levels.
• Other laxatives or stool softeners: additive effect may lead to excessive bowel movements.
• Certain antibiotics (e.g., tetracyclines): reduced absorption due to delayed gastric emptying.